U.S. PET-CT Scanner Market– By Type, By Modality, By Slice Count, By Application, By End Use – Forecast, 2024 – 2032

U.S. PET-CT Scanner Market Size

The U.S. PET-CT scanner market size was valued at around USD 864 million in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032. A PET-CT scanner is a medical imaging equipment that integrates positron emission tomography (PET) and computed tomography (CT) into a single machine. While utilizing radioactive tracers, PET scans track the cell's metabolic activity, and CT scans offer highly defined structural images.
 

This technology enables the functional and anatomical information of the body to be acquired simultaneously, which in turn improves the diagnosis, especially in oncology, cardiology, and neurology. The continuous innovations leading to improved product launches, all aimed at improving the quality of imaging and minimizing the scan time, are the primary growth determinants for the market.

Also, one of the most important developments observed is the introduction of digital PET scanners with advanced sensitivity and resolution, which will greatly accelerate the growth of this market. Rising cases of cancer in the U.S. is positively influencing market growth. For instance, cancer is the second most common cause of death in the U.S. Thus, the increasing need of more efficient cancer diagnosis is a driving force for the enhancement of better tools which stimulate the growth and demand of the PET-CT scanner market.
 

Moreover, the increasing popularity of the U.S. health system’s emphasis on personal therapy has also led to increased use of PET scans, especially on tumor sites, and in evaluating response to treatment. In addition, collaborative efforts between technological enterprises and medical institutions are promoting the innovation of new radiotracers, thus accelerating market expansion.
 

U.S. PET-CT Scanner Market Trends

• The market is broadly driven by the soaring cases of cancer in the U.S. Due to the increase in cancer occurrence, advanced diagnostic aids such as PET CT scanners are in great demand for timely diagnosis, accurate staging, and treatment progress assessment.
   

• Since the early detection of cancer is critical to successful treatment, the growing cancer burden in the population is increasing the demand for additional PET CT scanners in healthcare services, hospitals, and specialized diagnostic clinics, thereby driving market growth.
   
• Additionally, growing inclination towards minimally invasive diagnostic procedures further catalyzes the market growth. Also, the advances in radiopharmaceuticals are increasing the scope of use for PET-CT imaging. New tracers are being developed to improve the pathology of certain diseases or cellular mechanisms, which allow greater versatility for PET-CT scanners in different areas of medicine.
   

U.S. PET-CT Scanner Market Analysis

Based on type, the market is segmented into digital and analog. The digital segment dominated the market with the largest revenue of USD 511.8 million in 2023 and is expected to grow at a significant CAGR over the forecast period.
 

• The digital PET-CT scanners are the most employed, as they have better image quality, greater resolution, and faster scan times, unlike the analog devices. The Vereos PET/CT system is an example of a digital PET-CT scanner that is built with innovative technology that counts photons, which improves the resolution, sensitivity, and stability of the system compared to standard analog systems.
   
• Additionally, digital PET-CT scanners offer higher accuracy in diagnosing different conditions such as cancer, heart problems, and brain issues. According to a report released in February of 2020 by European Journal of Nuclear Medicine and Molecular Imaging, digital PET/CT systems are superior to analog systems in the detection of lesions, and such systems may enable health professionals to confidently diagnose patients with a 37% to 44% greater chance of validation.
   
• Also, operationally, digital PET-CT systems are more useful due to reduced scan periods, lower exposure to radiation, and decreased operational expenses owing to fewer hardware components. In consequence, the enhanced efficiency and cost-effectiveness of these systems ensures adoption, thus fueling market growth in the coming years.
   

Based on modality, the U.S. PET-CT scanner market is segmented into fixed and mobile. The mobile segment of the market, which held a 39.8% share in 2023, is poised for substantial growth in the coming years.
 

• The adoption of mobile PET-CT scanners has been growing rapidly, mainly due to the increased need for healthcare services and flexibility.
   
• Further, mobile units can be stationed at different locations to provide services to more patients, especially in rural areas where accessibility to specialist diagnostic tools is scarce.
   
• Therefore, both large medical hubs and small healthcare clinics are adopting mobile PET-CT scanners due to the high level of convenience that comes with them.
   

Based on slice count, the U.S. PET-CT scanner market is segmented into high slice, medium slice, and low slice. The medium slice segment of the market, which held a 52.3% share in 2023, is poised for substantial growth in the coming years.
 

• Medium-slice PET-CT scanners generally have 16 to 64 detector slices. They are most useful for cost-effective imaging as they yield high-resolution images more than their high-slice counterparts. These devices are essential in oncology, cardiology, and neurology because they provide images of metabolic activity in addition to anatomical structures.
   
• These scanners are relatively inexpensive compared to the other larger and high-slice PET-CT systems and, hence, are quite popular in clinical practice.
   
• With the healthcare system gradually embracing new diagnostic tools, it is safe to say that the medium-slice segment is set to maintain a stable market outlook, further increasing their foothold in the U.S PET-CT scanner market.
   

Based on application, the U.S. PET-CT scanner market is segmented into cardiology, oncology, neurology, and other applications. The oncology segment dominated the market with the largest revenue of USD 697.2 million in 2023 and is expected to grow at a significant CAGR over the forecast period.
 

• With the rising cases of cancer across the U.S. population, the emphasis on early diagnosis and efficient monitoring has helped to increase the use of PET-CT scanners in oncology. Also, with the development of healthcare systems, the role of PET-CT in oncology diagnostics and treatment monitoring is expected to expand due to innovations and easier access to healthcare.
   
• In addition, the persistent improvements in the technology of PET – CT have enhanced its market leadership in the oncology segment.
   

Based on end-use, the U.S. PET-CT scanner market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, research institutes, and other end users. The hospitals segment of the market, which held a 59.1% share in 2023, is poised for substantial growth in the coming years.
 

• The hospitals segment is poised to capture substantial revenue share of the market owing to the increased use of sophisticated imaging systems for diagnostic and treatment planning activities.
   
• As an important sector of the health industry, hospitals are purchasing more PET-CT scanners to enhance the efficacy of cancer diagnosis, staging, and monitor the treatment response.
   
• Therefore, with patients becoming more aware of the significance of comprehensive diagnostic imaging, it has started to affect how hospitals make technology investment decisions, which further leads to an increase in the number of healthcare facilities with PET-CT scanners.
   

The Northeast zone dominated the U.S. PET-CT scanner market with the largest revenue of USD 177.1 million in 2023 and is projected to witness substantial growth over the forecast period.
 

• The Northeast U.S. has a sizable healthcare system with several academic medical institutions, clinics, and outpatient imaging centers that offer PET-CT diagnostics services, which enables them to offer overall better healthcare services.
   
• Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, in Boston, are part of the National Cancer Institute's Cancer Centers Program that focuses on comprehensive cancer centers situated in the Northeast. They have a high dependency on advanced medical imaging technology, which increases the supply of PET-CT scanners needed in this area.
   
• In addition, the Northeast region is central to medical research and clinical trials, which further increases the adoption of PET-CT scanners, driving the overall market growth.
   

U.S. PET-CT Scanner Market Share

The market is composed of several key players in the industry. The leading players of the industry often work in building new possibilities in the healthcare market. For example, Siemens Healthineers, Koninklijke Philips, and GE Healthcare are some of top companies that have a wide array of products consisting of PET-CT scanners with better imaging and accuracy.
 

Continuous product launches by key players are driving the PET-CT scanner market, as these launches encourage competition and divergence within the market making companies more willing to spend money on research and development so that they will not face stiff competition and always meet the needs of the changing market. Such competition encourages new advantages for patients and healthcare professionals in PET-CT's technology that leads to more innovation, better efficacy, and newer applications.
 

U.S. PET-CT Scanner Market Companies

Some of the eminent market participants operating in the U.S. PET-CT scanner industry include:

• Bruker Corporation
• Canon
• GE HealthCare
• Koninklijke Philips
• Mediso
• MinFound Medical Systems
• MR Solutions
• Neusoft Medical Systems
• Siemens Healthineers
• Shanghai United Imaging Healthcare
• SOFIE
   

USPs of top players

• Strong distribution networks with key partners around the globe to aid in better market penetration.
   
• Collaborations and partnerships with hospitals, diagnostic imaging centers, and research institutes aid in gaining a competitive edge in the market.
   

U.S. PET-CT Scanner Industry News:

• In May 2023, GE HealthCare announced U.S. FDA clearance of its Precision DL, a new, revolutionary deep learning-based image processing software to enhance image quality in PET/CT. This approval enhanced the company's position in AI and diagnostic imaging market.
   
• In July 2022, Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation, announced its acquisition of NXC Imaging, a Minneapolis-based distributor and service provider of medical imaging equipment. This strategic move enhanced Canon's sales and service capabilities across the Upper Midwest.
   

The U.S. PET-CT scanner market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Digital
• Analog

Market, By Modality

• Fixed
• Mobile

Market, By Slice Count

• High slice
• Medium slice
• Low slice

Market, By Application

• Cardiology
• Oncology
• Neurology
• Other applications

Market, By End Use

• Hospitals
• Diagnostic centers
• Ambulatory surgical centers
• Research institutes
• Other end users

The above information is provided for the following zones:

• East North Central
• West South Central
• South Atlantic
• Northeast
• East South Central
• West North Central
• Pacific Central
• Mountain States